Skip to main content
Equibles

VANGUARD PORTFOLIO MANAGEMENT LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 2100121 MALVERN, PA
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$153,735,502
-$13,672,539 QoQ
Shares Held
3,305,429
+2.1% QoQ
Ownership
5.69%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 335 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

VANGUARD PORTFOLIO MANAGEMENT LLC holds $7,792,404,186 across 40 Drug Manufacturers - Specialty & Generic names. SUPN ranks #11 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 23,860,445 $1,714,611,577
2 UTHR
UNITED THERAPEUTICS Corp
 1,919,429 $1,040,004,215
3 VTRS
Viatris Inc
 54,282,080 $861,999,430
4 NBIX
Neurocrine Biosciences Inc
 4,974,083 $838,331,948
5 ELAN
Elanco Animal Health Inc
 22,672,312 $557,965,598
6 ALKS
Alkermes plc.
 9,490,818 $497,318,863
7 HIMS
Hims & Hers Health, Inc.
 10,559,314 $366,091,416
8 LNTH
Lantheus Holdings, Inc.
 3,238,471 $359,275,972

All Filings in SUPN

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $153,735,502 3,305,429
2026-03-31 $167,408,041 3,238,693